ZEVALIN Plus High Dose Chemotherapy (Z-BEAM) Highly Effective in Aggressive ... MarketWatch (press release) In the era of rituximab-containing frontline regimens, it is becoming more challenging to salvage patients with ASCT in this setting, and novel approaches are required. This was a randomized study evaluating the safety and efficacy of standard-dose ... |
